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Objective: Because patient-level differences do not fully explain the variation in lower extremity amputation rates across
the United States, we hypothesized that variation in intensity of vascular care may also affect regional rates of amputation
and examined the relationship between the intensity of vascular care and the population-based rate of major lower
extremity amputation (above-knee or below-knee) from vascular disease.
Methods: Intensity of vascular care was deﬁned as the proportion of Medicare patients who underwent any vascular
procedure in the year before amputation, calculated at the regional level (2003 to 2006), using the 306 hospital referral
regions in the Dartmouth Atlas of Healthcare. The relationship between intensity of vascular care and major amputation
rate, at the regional level, was examined between 2007 and 2009.
Results: Amputation rates varied widely by region, from one to 27 per 10,000 Medicare patients. Compared with regions
in the lowest quintile of amputation rate, patients in the highest quintile were commonly African American (50% vs 13%)
and diabetic (38% vs 31%). Intensity of vascular care also varied across regions: <35% of patients underwent revascu-
larization in the lowest quintile of intensity, whereas nearly 60% underwent revascularization in the highest quintile.
Overall, an inverse correlation was found between intensity of vascular care and the amputation rate, ranging from
R[L0.36 for outpatient diagnostic and therapeutic procedures to R[L0.87 for inpatient surgical revascularizations.
Analyses adjusting for patient characteristics and socioeconomic status found patients in high-intensity vascular care
regions were signiﬁcantly less likely to undergo amputation without an antecedent attempt at revascularization (odds
ratio, 0.37; 95% conﬁdence interval, 0.34-0.37; P < .001).
Conclusions: The intensity of vascular care provided to patients at risk for amputation varies, and regions with the most
intensive vascular care have the lowest amputation rate, although the observational nature of these associations do not
impart causality. High-risk patients, especially African American diabetic patients residing in low-intensity vascular care
regions, represent an important target for systematic efforts to reduce amputation risk. (J Vasc Surg 2013;57:1471-80.)Lower extremity peripheral arterial disease (PAD)
manifests as critical limb ischemia (CLI) in nearly 1 million
Medicare patients per year,1-7 with an estimated annual
cost of >$3 billion.8 Despite an increase in health care
resources directed to CLI in recent years,9 major lowerthe Section of Vascular Surgery, Dartmouth-Hitchcock Medical
enter, Lebanona; the Dartmouth-Hitchcock Medical Center, The Dart-
outh Institute for Health Policy and Clinical Practice, Hanoverb; The
niversity of Michigan Center for Health Outcomes and Policy, Ann
rborc; the Center for Outcomes Research and Evaluation, Maine
edical Center, Portlandd; and The Institute for Evaluative Clinical
iences, Toronto, Ontario, Canada.e
was supported by a K-08 Career Development Award from the
ational Heart Lung and Blood Institute (1K08HL05676) and an
merican Vascular Association/American College of Surgeons Supple-
ental Funding Award.
or conﬂict of interest: none.
ented at the 2012 Vascular Annual Meeting of the Society for Vascular
rgery, Washington, DC, June 7, 2012.
itional material for this article may be found online at www.jvascsurg.org.
rint requests: Philip P. Goodney, MD, MS, Dartmouth-Hitchcock
edical Center, 1 Medical Center Dr, Lebanon, NH 03766 (e-mail:
ilip.goodney@hitchcock.org).
editors and reviewers of this article have no relevant ﬁnancial relationships
disclose per the JVS policy that requires reviewers to decline review of any
anuscript for which they may have a conﬂict of interest.
-5214/$36.00
yright  2013 by the Society for Vascular Surgery.
://dx.doi.org/10.1016/j.jvs.2012.11.068extremity amputation remains common and varies widely
across regions of the United States (U.S.).10-14 For
example, the rate of major leg amputation in Corpus
Christi, Tex, is 24 amputations/10,000 Medicare patients,
which is more than six times higher than the rate of four
amputations/10,000 in Grand Junction, Colo.
Regional differences in amputation rates have been
ascribed, at least in part, to patient-level factors such as
race and socioeconomic status.10 However, because
patient-level differences do not fully explain the variation
in the amputation rate across regions, we hypothesized
that variation in the intensity of vascular care may also
affect regional rates of amputation. We demonstrated in
previous research that a signiﬁcant variation exists in the
intensity of vascular care across different regions of the
U.S.15 In some regions, such as Elyria, Ohio, and Santa
Cruz, Calif, patients commonly undergo multiple invasive
vascular treatments for CLI that involve several endovascu-
lar interventions and open surgical procedures. In other
regions, however, such as Sayre, Pa, and Bryan, Tex,
patients commonly undergo less-intense vascular care and
receive fewer open and endovascular revascularization
procedures for CLI.
However, it remains unknown if, in vascular care,
“more is better”; that is, if patients who live in regions
where vascular care is more intense have a lower likelihood1471
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sought to characterize, at the regional level, the relation-
ship between the intensity of vascular care and the
population-based amputation rate in patients with CLI.
By studying variations in intensity of vascular care, we
hope to gain insight into the effectiveness of different levels
of intensity of vascular care in preventing amputation.
METHODS
Institutional Review Board approval for this study was
obtained from the Committee for Protection of Human
Subjects from Dartmouth Medical School.
Overview. Overall, we studied the relationship be-
tween intensity of invasive vascular care and amputation
using (1) regional-level comparisons between intensity of
vascular care and amputation rate and (2) analysis of
patient characteristics, structural processes of care, and
their associations with an individual patient’s risk of
undergoing amputation for PAD without an attempt at
revascularization.
Peripheral vascular disease can vary from intermittent
claudication, where amputation risk is minimal, to CLI,
where amputation risk is high.16 To ensure that we studied
vascular care focused on the treatment of CLI, rather than
discretional treatment of claudication, we designed our
study in two important ways. First, we examined invasive
vascular care provided to patients in the year before major
limb amputation as a result of PAD. Research using
regional and national data sets has shown that vascular
procedures, either diagnostic or therapeutic, performed in
the year before amputation are almost always related to
treatment of CLI rather than to treatment of intermittent
claudication.17 Second, because all patients used to deﬁne
intensity of vascular care ultimately undergo amputation,
this measure is, by design, less sensitive to variation across
regions in rates of non-limb-threatening peripheral vascular
disease.15
Assembling a cohort of patients undergoing am-
putation for PAD. We used the Medicare Physician/
Supplier ﬁle and the Medicare Denominator ﬁle from the
years 2003 to 2009 to identify patients aged $66 years
undergoing major leg amputation. Also used was the Physi-
cian/Supplier ﬁle, which contains all claims submitted by
physicians for performance of procedures under the Medi-
care Part B program and includes Current Procedural
Terminology (American Medical Association, Chicago,
Ill) codes,18 International Classiﬁcation of Diseases-9th
edition (ICD-9) diagnosis codes, date of procedure, and
age, sex, and race of the beneﬁciary receiving the proce-
dure. Vital status was determined using the Denominator
ﬁle, which contains information about eligibility by year for
Part B and information about age, sex, and race of eligible
beneﬁciaries. We recorded patient comorbidities, including
Charlson Comorbidity Index scores, as well as zip code and
hospital referral region (HRR) of residence, as described by
the Dartmouth Atlas of Healthcare.19
Deﬁning regional intensity of vascular care. As
reported previously, we examined regional utilization ofinvasive vascular care in the year before major amputation
for PAD.15 Using Medicare claims during the ﬁrst 3
years in our study period (2003 to 2006), we deﬁned the
regional intensity of vascular care in two ways:
First, we deﬁned regional intensity as the proportion of
amputees who underwent at least one revascularization
procedure during the 2 years before amputation. This
proportion was calculated for each HRR, and HRRs were
then ranked according to this measure. These assessments
included the average number of open revascularizations
and endovascular procedures received before amputation
among amputees. Further, we also examined the proportion
of amputees undergoing only open revascularization before
amputation, as well as the proportion undergoing only
endovascular procedures before amputation, to assess the
effect of each of these patterns of procedural use on ampu-
tation rates.
Second, because many endovascular interventions are
performed in ambulatory settings andwould not be captured
with inpatient-speciﬁc analyses, we examined the intensity of
care as a function of the proportion of patients who under-
went any open or endovascular revascularization procedure,
diagnostic and therapeutic, performed as an inpatient or
outpatient. Medicare Part B claims, which include inpatient
and outpatient procedures, were used for this analysis. This
ensured the broadest possible capture of all types of diag-
nostic and therapeutic vascular care, such as care provided
to patients who may have received outpatient diagnostic
angiography but could not undergo revascularization. A
map demonstrating variation in regional intensity of vascular
care is shown the Supplementary Fig (online only), and the
procedural codes used to calculate intensity of care are
detailed in the Supplementary Table (online only).
To ensure patient conﬁdentiality and anonymity, in
accordance with rules regarding the use of Medicare claims,
we excluded HRRs with <30 amputations from our regres-
sion model during the study period (99 of the 306 HRRs
[32%]), and we do not present any ﬁndings from these
regions in the analyses reported here. Patient characteristics
were similar between included and excluded regions, and
the direction and magnitude of our effect was similar
when we included regions with <30 amputations in our
regression models or when higher thresholds, such as 40
or 50 amputations, were used. However, in accordance
with prior publications from the Dartmouth Atlas, we
excluded HRRs where <30 events occurred.20
Calculating regional population-based amputation
rates. Population-based regional amputation rates were
calculated using the total number of patients undergoing
major amputation for PAD as the numerator and the total
number of patients (determined from the midyear census
estimate) in the region as the denominator. We included
below-knee and above-knee amputation. The analysis
excluded patients undergoing minor amputations, such as
forefoot or toe amputations, or traumatic amputations.
Given that we used the ﬁrst 3 years (2003 to 2006) in our
study to deﬁne the exposure variable, we used Medicare
claims from the latter 3 years (2007 to 2009) to identify all
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extremity for PAD, using ICD9 and CPT codes as deﬁned
in the Supplementary Table (online only), to study the
effect of our exposure variable. Of note, analyses were
performed using only patients with PAD as our denomi-
nator, but these analyses revealed similar size and direction
of effect, and therefore for clarity, are not presented here.
After calculating regional intensity of vascular care and
population-based regional rates of major amputation, we
examined the associations between these two variables. These
associations were displayed using scatterplots between the
exposure variable and the outcome variable, at the regional
level. Correlation coefﬁcients between the exposure and the
outcome were calculated. We performed similar comparisons
in aggregate by quintile of population-based amputation
rates. Differences across quintiles were tested using c2 anal-
yses and nonparametric tests of trend.
Patient-level analysis. We investigated demographic
and structural characteristics associated with patients who
underwent amputation without antecedent vascular care.
To examine which patients were most likely to undergo
amputation without revascularization, we studied associa-
tions at the patient level among patient characteristics,
regional intensity of vascular care, and the risk of under-
going amputation without revascularization. We performed
stepwise multivariable logistic regression to determine the
associations between patient and structural characteristics
and the likelihood of amputation without revascularization.
Model ﬁt was assessed using goodness-of-ﬁt testing, and
receiver-operating characteristic curve assessment was used
to assess model discrimination. All calculations were per-
formed using SAS (SAS Institute, Cary, NC) and STATA
(StataCorp LP, College Station, Tex) software.
RESULTS
Population-based amputation rate by region. Popu-
lation-based amputation rates varied across regions, from less
than one per 10,000 Medicare patients to >27 per 10,000
Medicare patients (Fig 1). For example, population-based
amputation rates in Mesa, Ariz, and Chico, Calif, were less
than one per 10,000 Medicare patients but were >23 per
10,000 in Florence, SC, Meridian, Miss, and McAllen, Tex.
Across the U.S., the 2007 to 2009 population-based
major amputation rate due to PAD was 8.9 per 10,000
Medicare patients. The amputation rate was much higher
among African American patients (34.8 per 10,000) than
in non-African American patients (7.6 per 10,000;
P < .0001) and in patients with diabetes (15.7 per
10,000) than in patients without diabetes (6.8 per
10,000; P < .0001). Gender also was associated with
differences in amputation rate (12.6 per 10,000 men vs
7.4 per 10,000 women; P < .001).
We identiﬁed 94,873 patients who underwent major
amputation due to PAD between 2007 and 2009. Patients
who underwent amputation were elderly (mean, 77.2
years), more commonly male than female (55.1% vs
41.8%; P < .001), and nearly four times more likely to
be African American than other races (26.5% vs 7.3%;P < .001). When comorbidities were assessed, patients
undergoing major amputation commonly had diabetes
(35%), congestive heart failure (58%), coronary artery
disease (24%), and chronic renal insufﬁciency (41%).
Patient characteristics by population-based ampu-
tation rate. Patient characteristics varied across quintiles of
population-based amputation rates (Table I). Compared
with patients in regions in the lowest quintile of amputa-
tion rate, patients in regions with the highest quintile of
amputation rate were similar in age (mean, 78 years) and
comorbidity status (Charlson Comorbidity Score of 3.3 in
regions of very low amputation rates and 3.6 in regions
with very high amputation rates; P ¼ .289). The incidence
of diabetes was 38% in regions with high amputation rates
compared with 31% in regions with very low amputation
rates (P ¼ .002). Per-capita income was $17,980 in high-
amputation-rate regions compared with $19,454 in low-
amputation-rate regions (P < .0001). Finally, patients in
high-amputation-rate regions were much more likely to
be African American (50%) compared with very low-
amputation-rate regions (13%; P < .0001).
Associations between intensity of vascular care and
amputation rate. Overall, we found an inverse relation-
ship between intensity of invasive vascular care and the
regional rate of major amputation (Fig 2). This relation-
ship between intensity of care and amputation rate was
strongest when we examined patients undergoing thera-
peutic revascularization procedures, occurring in an inpa-
tient setting, as a primary measure of intensity of vascular
care (R ¼ 0.82; Fig 2, A). Similarly, when we considered
intensity of vascular care speciﬁcally using open surgical
revascularizations, there was again a strong and inverse
correlation between intensity of vascular care and regional
amputation rates (R ¼ 0.87; Fig 2, B). This relationship
was attenuated when we speciﬁcally considered therapeutic
endovascular procedures as a measure of vascular intensity
(R ¼ 0.58; Fig 2, C). Finally, this relationship was further
attenuated when we considered diagnostic and therapeutic
revascularization procedures performed in inpatient or
outpatient settings (R ¼ 0.36; Fig 2, D).
We next calculated the relative use of revascularization
procedures and amputations across strata of population-
based amputation rates. In regions with low or moderate
amputation rates, patients underwent between four and
ﬁve therapeutic revascularization procedures in 2003 to
2006 for each amputation performed in 2007 to 2009
(Fig 3, A). However, the use of revascularization was
inversely related to the amputation rate at the regional
level, although this effect was most evident at the lowest
strata of vascular intensity. For example, patients in the
regions in the highest quintile of amputation rate under-
went 54% fewer open or endovascular therapeutic revascu-
larizations for each amputation compared with patients in
regions with a moderate amputation rate (4.8 vs 2.2 prior
revascularizations per amputation; P < .001). These trends
were similar across diagnostic procedures, open surgical
procedures, therapeutic vascular procedures, and combina-
tions of these treatments (Fig 3, B).
Fig 1. Population-based amputation rates for peripheral arterial disease (PAD) by hospital referral regions are shown
on the map.
Table I. Characteristics of patients undergoing amputation, by quintile of amputation rate
Variable
Quintile of amputation rate (n ¼ 94,873)
Ratioa P (ANOVA)Very low Low Medium High Very high
Age, mean years 78.3 78.0 78.4 78.8 78.7 1.00 .104
Male, % 54.9 53.4 50.5 46.9 47.7 0.87 <.001
African American, % 12.8 17.4 26.1 34.2 50.3 3.93 <.001
Diabetes, % 30.8 33.6 36.5 35.4 38.4 1.25 .002
Congestive heart failure, % 34.4 35.0 35.4 36.2 36.5 1.06 .256
Coronary artery disease, % 13.4 13.1 14.6 15.2 11.5 0.85 .01
Renal insufﬁciency, % 16.1 17.0 19.0 17.5 18.0 1.11 .011
Charlson Comorbidity Score 3.3 3.3 3.5 3.6 3.6 1.08 .289
Per-capita income, $ 19,454.22 19,286.93 19,237.19 18,687.09 17,980.95 0.92 .001
ANOVA, Analysis of variance.
aVery high to very low.
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intensity of vascular care. Overall, there were 12 regions
of the U.S. where amputation rates were in the highest
quintile, but intensity of vascular care was in the lowest
quintile. These regions were generally located in the South,
namely Louisiana (Lafayette, Shreveport), Mississippi
(Jackson, Meridian, Tupelo), North Carolina (Durham,
Greensboro, Greenville), South Carolina (Columbia, Flor-
ence), Tennessee (Memphis), and Virginia (Lynchburg).When compared with patients in the lowest-amputation-
rate regions, patients in these regions were similar in age
(mean, 78 years), proportion that were male (w50%),
Charlson Comorbidity Score (2.7 vs 2.8), as well as other
comorbidities such as history of myocardial infarction, renal
insufﬁciency, and congestive heart failure. However, the
proportion that was African American was dramatically
higher in these regions than in the rest of the country (62%
vs 12%; P < .0001). Conversely, in regions with high
Fig 2. Correlation at the regional level is shown between intensity of vascular care and amputation rate. Intensity of
vascular care is measured as a function of (A) all inpatient revascularizations, (B) all inpatient open surgical revascu-
larizations, (C) inpatient therapeutic endovascular procedures, and (D) inpatient and outpatient diagnostic and
therapeutic, open and endovascular revascularization procedures. *Amputation rates speciﬁes major (above or below)
knee amputation rate per 10,000 Medicare beneﬁciaries. yIntensity of care measured as a function of the number of
procedures performed in the year prior to amputation.
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in the proportion of patients whose amputation was not
preceded by revascularization (41% African American, 40%
white; P ¼ .64).
Multivariable analysis of patient characteristics and
amputation without revascularization. In analyses ad-
justing for age, sex, race, income, and comorbidities,
patients in the highest-intensity regions remained less likely
to undergo amputation without revascularization (odds
ratio, 0.37; 95% conﬁdence interval, 0.34-0.41;
P < .001; Table II). This model had good discriminative
ability and ﬁt the observed observations (area under the
curve, 0.74; goodness of ﬁt, P ¼ .347). Although differ-
ences were attenuated compared with univariate analyses,
African American patients remained signiﬁcantly more
likely to undergo amputation without an antecedent
attempt at revascularization, even when adjusting for
treatment intensity.
DISCUSSION
In many regions of the U.S., most patients with severe
PAD undergo major amputation without having receivedany invasive vascular care in the year before amputation;
and frequently, these same regions have the highest overall
population-based rates of amputation. Conversely, regions
with moderate population-based amputation rates perform
nearly twice as many revascularization procedures for each
amputation. These treatment patterns are unlikely to be
driven solely by health insurance, because all patients in
this analysis were aged >65 years and insured by Medicare.
Although differences in regional amputation rates are partly
due to patient characteristics, such as race and diabetes, our
results suggest that regional intensity of invasive vascular
care is an important determinant of each patient’s risk of
major limb amputation.
Why might patients in low-intensity vascular care
regions not be offereddor choose not to undergod
revascularization procedures for CLI? Our hypothesis is
that in regions with poor health care access, patients with
CLI commonly present late in their disease process. Research
has suggested that regions with few vascular specialists have a
higher population-based risk of amputation,21 and our study
furthers this hypothesis. Patients with extensive gangrene,
ulceration, and infection, whose disease has often become
so advanced because of poor access to care, commonly lose
Fig 3. A, The mean number of revascularization procedures (therapeutic endovascular interventions or bypass surgery)
for each amputation is shown by the quintile of the population-based amputation rate. *P is for nonparametric test of
trend across all regions. B, The mean number of other vascular procedures for each amputation is shown by the quintile
of the population-based amputation rate.
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because they present too late in their disease process and
the need to control ascending sepsis may necessitate primary
amputation. This effect seems most apparent in African
American patients, especially in Southern regions of the
U.S., and this effect has been shown in other examinations
of utilization of vascular care before amputation in African
American patients.22 Our analysis, as well as others,15,23-25
found African Americans, especially those with diabetes,
have a very high risk for lower extremity amputation. Several
studies, using single-center, regional, and national data sets,
have conﬁrmed this relationship.23,26-28 Physiologic covari-
ates, such as obesity, metabolic syndrome, chronic obstruc-
tive pulmonary disease, and smoking, explain a portion of
this effect, but the magnitude of these effects has varied
across studies and does not fully explain why these patients
have such dramatically higher risks of amputation.10
Although acknowledging that our analysis has limited
physiologic detail, our work begins to focus on the struc-
tural aspects of care associated with limb loss due toPAD, especially apparent in African American patients.
Overall, patients who undergo amputation without an
attempt at revascularization are more likely to live in
regions of the U.S. where invasive vascular care is less
intensive. Our analysis showed much (45%) of the excess
risk of amputation in African American patients was
explained by a low intensity of vascular care. Perhaps
even more simply, we found that when African American
patients lived in regions where intensity of vascular care
was high, there was no difference in the incidence of ampu-
tation without prior revascularization between African
American and white patients. Therefore, our study appears
to demonstrate that the higher risk of amputation in
African American patients is at least partially explained by
the structural aspects of their care.
How can we improve care for patients with CLI who
are at risk for amputation? Prior efforts have involved
a broad approach to screening and education and have
not been highly “targeted.” For example, HealthyPeople.
gov, a large community-based educational initiative aimed
Table II. Multivariable logistic regression model
identifying risk factors at the patient level associated with
undergoing amputation without an attempt at
revascularization
Variable OR (95% CI) P
Age, years
65-70 Referent
71-75 1.02 (0.93-1.12) .714
76-80 1.12 (1.02-1.24) .02
81-85 1.42 (1.29-1.56) <.001
>85 2.29 (2.07-2.53) <.001
History of
Myocardial infarction 0.8 (0.73-0.89) <.001
Cerebrovascular disease 1.12 (1.01-1.24) .025
Diabetes 1.14 (1.06-1.22) <.001
African American race 1.16 (1.08-1.25) <.001
Charlson Comorbidity Score
1st tercile Referent
2nd tercile 1.19 (1.09-1.3) <.001
3rd tercile 1.22 (1.11-1.35) <.001
Regional intensity of vascular care
Very low Referent
Low 0.72 (0.65-0.79) <.001
Medium 0.6 (0.54-0.66) <.001
High 0.52 (0.47-0.57) <.001
Very high 0.37 (0.34-0.41) <.001
CI, Conﬁdence interval; OR, odds ratio.
Area under the curve ¼ 0.74.
Goodness of ﬁt P ¼ .347.
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has focused on broad ambulatory settings to improving
preventive care.29 These programs broadly recommended
increased screening efforts for PAD and diabetes.29,30
However, results from these community-based initiatives,
in terms of reducing amputation rates, have not been
dramatic.31
Given the lack of effect from broad initiatives aimed
at prevention, our ﬁndings offer a blueprint for a new
approach toward improving the care of patients at risk for
amputation. Our study delineates the regions at the highest
risk for amputation and demonstrates that invasive vascular
care is provided at a low intensity in many of these regions.
Our work suggests that policy makers and clinicians should
focus new efforts aimed at preventing amputation on
regions where amputation risk is highest and current inten-
sity of vascular care is low.
What should these new efforts entail? Recent studies
suggests that integrated amputation-prevention teams,
addressing podiatric care and medical care for diabetes,
hypertension, hyperlipidemia, and vascular disease will
have the most impact, especially in patients at the highest
risk of amputation.32 Our demonstration of regional varia-
tion suggests that such efforts should focus their multidis-
ciplinary work toward amputation prevention in the
regions our study has identiﬁed as having the highest
amputation rates as well as the lowest intensity of care.33
These regions are likely the ideal forum in which to test
such programs, given the signiﬁcant potential forimprovement in amputation rates. Therefore, our future
work will seek to understand the effect not only of variation
in vascular care on amputation risk but also of multidisci-
plinary preventive care (such as podiatric visits, wound
care, diabetic monitoring, and pharmacotherapy) on ampu-
tation risk in patients with critical limb ischemia. Under-
standing these processes, including the potential for
overuse of vascular care, may help to improve access for
patients who currently have limited ability to receive
complex care aimed at preventing amputation.
Our study has several important limitations. First, we
used an easily measurable and distinctive clinical event
(lower extremity vascular procedures) as a proxy for overall
“intensity” of vascular care. We recognize that although
this event is an important aspect of limb salvage, medical
care for patients with vascular disease, including statin
and antiplatelet therapy, podiatric care, and diabetic care,
remains equally important in achieving successful
outcomes.16 However, prior work suggests that invasive
vascular care intensity acts as an acceptable surrogate for
these measures because patients referred for invasive
vascular procedures are also more likely to undergo inten-
sive hemoglobin A1C testing, statin therapy, and podiatric
consultation.9
Second, it is possible that the extent of comorbidities
could vary across regions in ways that were not measurable
using administrative data sets. We readily acknowledge that
the lack of clinical detail in our data set, as well as the obser-
vational nature of our data both preclude any determina-
tion of causality from our study; however, the consistency
of our effect makes this potential bias seem unlikely.
Third, it is possible that the period before amputation
used in our analysis was an inadequate interval within
which to study vascular care aimed at preventing amputa-
tion. However, studies of wound healing after limb revas-
cularization suggest this time period reﬂects an adequate
interval for care aimed at preventing amputation.27,34
Fourth, our patient population was limited to Medicare
patients, limiting the generalizability of our ﬁndings in
patients aged <65 years.
Fifth, although most patients with CLI and diabetes
require revascularization for limb salvage, diabetic patients
can present with palpable pedal pulses and severe, aggres-
sive infection and ulceration, such that amputation is neces-
sary without any need for revascularization. However, the
effect attributable to regional differences in intensity of
vascular care persisted, even when adjusting for regional
differences in diabetes, making systematic bias from dia-
betic patients unlikely.
CONCLUSIONS
Medicare patients living in regions with the highest
amputation rates are commonly African American, dia-
betic, and receive less invasive vascular care than patients
living in regions with much lower burdens of vascular
disease. In many aspects of health care in the U.S., many
argue that too much care is provided to patients who do
not necessarily beneﬁt.11,12 However, patients at risk for
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they reside in a region where vascular care is commonly
provided and a lower chance of keeping their limb if they
live in a region where care is not easily available. These
patients represent the best opportunity for integrated,
multidisciplinary efforts to reduce amputation risk.
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at www.jvascsurg.org.DISCUSSIONDr John Ricotta (Washington, DC). Some of the critics of
this type of analysis suggest that the regional approach blunts the
impact of local socioeconomic factors and that when you look at
areas within a region, the socioeconomics play a more important
role than the number and type of services within the broad region.
Isn’t it possible that the intensity of vascular care really reﬂects the
socioeconomic status of these various regions? I say this coming
from Washington, DC, where we have a very high incidence of
amputation, and I can assure you that we’ve got lots of vascular
surgeons. Many believe that access to care is the problem. I’m
not sure this is the case. My personal experience is that availability
of services is not the major problem. Rather, people of low socio-
economic status do not access the care that is available until it’s too
late. We see a lot of patients for the ﬁrst time where revasculariza-
tion is not an option.
Dr Philip P. Goodney. I think this reﬂects exactly that point.
And, much of the research, as it falls out of the Dartmouth Atlas,
is: Is too much health care being provided? And, I think our
project here shows that perhaps in this setting, health care is
needed for these patients, and it was needed earlier. These are
patients who have insurance, they have Medicare, and they should
have probably gotten more vascular care than they did in the year
prior to amputation.
So, Dr Ricotta, I think your point is well taken. There is a pop-
ulation of patients in whom vascular care is not aligned with need,
and that’s why I think our study shows not that we need more
vascular surgeons, but that we need to properly direct amputation
prevention initiatives toward those patients who need them the
most. So, I agree entirely with your discussion.
Dr Ronald Dalman (Stanford, Calif). Phil, I really am very
impressed with your continuing insight into these processes. I
want to just provide a cautionary observation about the validity
of some of these observations taken from 30,000” feet.
I noticed with interest that you mentioned that Santa Cruz,
California, for example, does well with amputations versus inten-
sity of vascular care, but there are, in fact, no board-certiﬁed
vascular surgeons practicing in Santa Cruz, and there are a number
of interventional radiologists and others who do a lot of proce-
dures but not amputations. So, when the patients ultimately do
need an amputation, they are referred to other regional “amputa-
tion centers,” with which we have some experience.
So, I would just point out this problem, which is when you
draw these conclusions taken from administrative databases, there
are a lot of other details that might be lost in translation, as far as
that goes.
Dr Goodney. That’s a great question, Dr Dalman. I appre-
ciate you bringing it up. All these analyses are based on a patient’s
zip code of residence, so it’s where they live, not necessarily where
they received their treatment. So, for exactly that point, one wants
to make sure the regions aren’t punished for providing high-risk
care. So, if your hospital is the referral center for the most complex
patients, this analysis wouldn’t necessarily penalize you. But, that’s
certainly a good point.In addition, our data is 30,000” data. However, the persistent
trend is that no matter how we looked at it, we found the same
effect and therefore we think it likely represents a real ﬁnding.
Dr John Hallett (Charleston, SC). Phil, I speak on behalf of
the Carolinas Vascular Study Group, because you’ve really focused
in our region.
I think there is an opportunity for the vascular study groups to
improve these results. In South Carolina, we were once 50th in the
country in terms of stroke because of hypertension. And, Dr Brent
Egan at the Medical University has led a statewide program that
improved hypertension therapy and reduced stroke over the last
25 years.
So, with this kind of information, we need to go back to our
regions where this is a problem and think about how we increase
access and education to decrease amputations.
Thank you very much for bringing this forward.
Dr Goodney.Well, thanks, Dr Hallett, and I appreciate it. As
the VQI gains momentum, I think that’s a perfect forum to
address this issue. I was pleased to see how these results from
our reﬂected changes that could potentially be made at a national
practice. And, I agree that the VQI could potentially serve as an
outstanding forum to push those changes ahead.
Dr Amy Reed (Hershey, Pa). I have two questions. Infection
often plays a role. How many of these patients had amputations for
infection, because clearly some of them don’t need the revascular-
ization procedures performed.
And also, with the advent of a lot of telemedicine, some of
that more in the VA, does your working group have any ideas of
how you might go forward or how we could take this out into
some of the underserved areas to use perhaps telemedicine? Are
there any other areas where telemedicine is being used and we
might be able to piggyback on that?
Dr Goodney. At the inception of this project, I wondered
that very question, and should the intensity of care ever be
100%, should all these patients get revascularization? The answer
is, of course, no, as certainly there is going to be the patient
with diabetes and palpable pulses who lost their foot because of
advanced local disease.
I don’t know exactly what that rate should be. I suspect it’s
somewhere in between 33% and 60%. The exact proportion of
amputations that had only infectious codes as compared to any
other of the PAD codes I would estimate at approximately 20%.
And, as for your second question, I think the VA will be where
we want to turn some of our efforts in the future because in
essence it obviates many of the access-to-care issues we’ve encoun-
tered here. There are vans that will bring you to the VA. There is
podiatric care integrated into vascular care there. So in some sense,
it might actually sort of simulate what we might aim towards in the
future. And, telemedicine will certainly play a big part in that.
Dr Eugene Lee (Sacramento, Calif). Is there a biologic effect
that may cause African-Americans to have higher amputation rates
or is race a surrogate for lower socioeconomic levels which may be
the actual cause for the higher amputation rates?
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similar amputation rates to their non-black counterparts, so at least
from the 30,000” level, I’d say maybe not. I’m certainly not a basic
scientist and that would be a presumption on my part to say that.
But, at least our data do not suggest that there are inherent differ-
ences. They seem to be reﬂected in patterns of practice.
Dr Hernan Bazan (New Orleans, La). Very nice presentation.
Were you able to look at age differences? The reason why I ask that
is because if you look at a map of stroke in the U.S. (the “stroke
belt”), it almost overlaps the map that you showed. There isa hypothesis that atherosclerotic disease is advanced in the
Southeast United States because of diet (high saturated fats),
smoking, and even cultural things that people do. So, I wonder
if you noted any differences in age and presentation in the South-
east or the areas where there are higher amputations than in other
areas?
Dr Goodney. We did see a strong effect by age, a more than
2.5-times effect in terms of the risk of undergoing amputation
without an antecedent revascularization, and those effects were
indeed stronger in the amputation belt.
Supplementary Fig (online only). Variation in the intensity of vascular care, by hospital referral region, as measured
by the proportion of patients in each region undergoing invasive vascular care in the year before amputation, 2003-
2006. PAD, Peripheral arterial disease.
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Supplementary Table (online only). International Classiﬁcation of Diseases-9th Edition (ICD-9) diagnosis codes used
to deﬁne peripheral arterial disease, and Current Procedural Terminology (CPT) procedural codes used to deﬁne
amputation procedures as well as open surgery and endovascular interventions.a
Open
Inﬂow
35521 Bypass graft, with vein; axillary-femoral
35351 Thromboendarterectomy, including patch graft, if performed; iliac
35355 Thromboendarterectomy, including patch graft, if performed; iliofemoral
35361 Thromboendarterectomy, including patch graft, if performed; combined aortoiliac
35363 Thromboendarterectomy, including patch graft, if performed; combined aortoiliofemoral
35537 Aortoiliac bypass
35538 Bypass graft, with vein; aortobi-iliac
35539 Bypass graft, with vein; aortofemoral
35540 Bypass graft, with vein; aortobifemoral
35541 Bypass graft, with vein
35546 Aortofemoral bypass with vein.
35539 Aortofemoral graft with vein. For aortofemoral graft with vein
35548 Bypass graft, with vein; aortoiliofemoral, unilateral
35549 Bypass graft, with vein; aortoiliofemoral, bilateral
35551 Bypass graft, with vein; aortofemoral-popliteal
35563 Bypass graft, with vein; ilioiliac
35565 Bypass graft, with vein; iliofemoral
35621 Bypass graft, with other than vein; axillary-femoral
35623 Bypass graft, with other than vein; axillary-popliteal or -tibial
35637 Bypass graft, with other than vein; aortoiliac
35638 Bypass graft, with other than vein; aortobi-iliac
35646 Bypass graft, with other than vein; aortobifemoral
35647 Bypass graft, with other than vein; aortofemoral
35651 Bypass graft, with other than vein; aortofemoral-popliteal
35654 Bypass graft, with other than vein; axillary-femoral-femoral
35661 Bypass graft, with other than vein; femoral-femoral
35663 Bypass graft, with other than vein; ilioiliac
35665 Bypass graft, with other than vein; iliofemoral
Outﬂow
35302 Thromboendarterectomy, including patch graft, if performed; superﬁcial femoral artery
35303 Thromboendarterectomy, including patch graft, if performed; popliteal artery
35304 Thromboendarterectomy, including patch graft, if performed; tibioperoneal trunk artery
35305 Thromboendarterectomy, including patch graft, if performed; tibial or peroneal artery,
35306 Thromboendarterectomy, including patch graft, if performed; each additional tibial
35371 Thromboendarterectomy, including patch graft, if performed; common femoral
35372 Thromboendarterectomy, including patch graft, if performed; deep (profunda) femoral
35533 Bypass graft, with vein; axillary-femoral-femoral
35556 Bypass graft, with vein; femoral-popliteal
35558 Bypass graft, with vein; femoral-femoral
35566 Bypass graft, with vein; femoral-anterior tibial, posterior tibial, peroneal artery
35571 Bypass graft, with vein; popliteal-tibial, -peroneal artery or other distal vessels
35583 In-situ vein bypass; femoral-popliteal
35585 In-situ vein bypass; femoral-anterior tibial, posterior tibial, or peroneal artery
35587 In-situ vein bypass; popliteal-tibial, peroneal
35656 Bypass graft, with other than vein; femoral-popliteal
35666 Bypass graft, with other than vein; femoral-anterior tibial, posterior tibial, or peroneal artery
35671 Bypass graft, with other than vein; popliteal-tibial or -peroneal artery
35681 Bypass graft; composite, prosthetic and vein
35682 Bypass graft; autogenous composite, two segments of veins from two locations
35683 Bypass graft; autogenous composite, three or more segments of vein
35879 Revision, lower extremity arterial bypass, without thrombectomy, open; with vein patch angioplasty
35881 Revision, lower extremity arterial bypass, without thrombectomy, open; with segmental vein interposition
35883 Revision, femoral anastomosis of synthetic arterial bypass graft in groin, open; with nonautogenous patch graft
35884 Revision, femoral anastomosis of synthetic arterial bypass graft in groin, open; with autogenous vein patch graft
Endovascular
Inﬂow
35452 Transluminal balloon angioplasty, open; aortic
35454 Transluminal balloon angioplasty, open; iliac
35472 Transluminal balloon angioplasty, percutaneous; aortic
35473 Transluminal balloon angioplasty, percutaneous; iliac
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Endovascular
35481 Transluminal peripheral atherectomy, open; aortic
35482 Transluminal peripheral atherectomy, open; iliac
35491 Transluminal peripheral atherectomy, percutaneous; aortic
35492 Transluminal peripheral atherectomy, percutaneous; iliac
Outﬂow
35456 Transluminal balloon angioplasty, open; femoral-popliteal
35459 Transluminal balloon angioplasty, open; tibioperoneal trunk and branches
35470 Transluminal balloon angioplasty, percutaneous; tibioperoneal trunk or branches, each vessel
35474 Transluminal balloon angioplasty, percutaneous; femoral-popliteal
35483 Transluminal peripheral atherectomy, open; femoral-popliteal
35485 Transluminal peripheral atherectomy, open; tibioperoneal trunk and branches
35493 Transluminal peripheral atherectomy, percutaneous; femoral-popliteal
35495 Transluminal peripheral atherectomy, percutaneous; tibioperoneal trunk and branches
37205 Transcatheter placement of an intravascular stent(s), (except coronary, carotid, and vertebral vessel), percutaneous;
initial vessel
37206 Transcatheter placement of an intravascular stent(s), (except coronary, carotid, and vertebral vessel), percutaneous;
each additional vessel
37207 Transcatheter placement of an intravascular stent(s), (noncoronary vessel), open; initial vessel
37208 Transcatheter placement of an intravascular stent(s), (noncoronary vessel), open; each additional vessel
Diagnostic only endovascular procedures
36200 Introduction of catheter, aorta
36245 Selective catheter placement, arterial system, each ﬁrst-order, lower- extremity
36246 Selective catheter placement, arterial system, second-order, lower- extremity
36247 Selective catheter placement, arterial system, third-order, lower- extremity
36248 Selective catheter placement, arterial system, beyond third order, lower- extremity
Outcome measure: amputation
27590 Amputation, thigh, through femur, any level
27591 Amputation, thigh, through femur, any level; immediate ﬁtting technique including ﬁrst cast
27592 Amputation, thigh, through femur, any level; open, circular (guillotine)
27880 Amputation, leg, through tibia and ﬁbula
27881 Amputation, leg, through tibia and ﬁbula; with immediate ﬁtting technique
27882 Amputation, leg, through tibia and ﬁbula; open, circular (guillotine)
28805 Amputation, foot; transmetatarsal
aAmerican Medical Association, Chicago, Ill.
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